The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TRYHARD, a randomized phase II trial (RTOG Foundation 3501) of concurrent accelerated radiation plus cisplatin (cis) with or without lapatinib (Lap) for stage III- IV Non-HPV head and neck carcinoma (HNC).
 
Stuart J. Wong
Research Funding - Merck; Novartis
 
Pedro A. Torres-Saavedra
No Relationships to Disclose
 
Nabil F. Saba
Honoraria - BioNTech; CUE Biopharma; Merck
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Bristol-Myers Squibb; Exelixis
Travel, Accommodations, Expenses - Blueprint Medicines; GlaxoSmithKline; Merck; Pfizer
 
George Shenouda
No Relationships to Disclose
 
Jeffrey Bumpous
No Relationships to Disclose
 
Robert E. Wallace
No Relationships to Disclose
 
Christine H. Chung
Consulting or Advisory Role - Bristol-Myers Squibb; CUE Biopharma; Mirati Therapeutics; Sanofi/Regeneron
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Ignyta (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Mirati Therapeutics
 
Adel K. El-Naggar
No Relationships to Disclose
 
Clement K Gwede
Research Funding - Florida Blue Foundation (Inst)
 
Barbara Burtness
Consulting or Advisory Role - Aduro Biotech; ALX Oncology; Celgene; CUE Biopharma; Debiopharm Group; IO Biotech; Ipsen; Macrogenics; Maverick Therapeutics; Merck; Nanobiotix; Oncolys BioPharma; Rakuten Medical
Research Funding - Aduro Biotech (Inst); Bristol Myers (Inst); CUE Biopharma (Inst); Exelixis (Inst); Formation Biologics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Debiopharm Group; Merck
 
Paul Tennant
No Relationships to Disclose
 
Neal E. Dunlap
No Relationships to Disclose
 
Loren K. Mell
Consulting or Advisory Role - Bayer
Research Funding - AstraZeneca; Merck
 
Sharon Spencer
No Relationships to Disclose
 
William A. Stokes
No Relationships to Disclose
 
Min Yao
Research Funding - Galera Therapeutics (Inst); Pfizer (Inst)
 
Darrion L Mitchell
No Relationships to Disclose
 
Jonathan Harris
No Relationships to Disclose
 
Walter J Curran
No Relationships to Disclose
 
Quynh-Thu Le
Stock and Other Ownership Interests - Aldea
Consulting or Advisory Role - GRAIL; Nanobiotix
Travel, Accommodations, Expenses - Genentech; Merck